Adroyd 5mg Tablet
By Adroyd
10 Tablet in a Strip

Composition
Oxymetazoline(5mg)

Manufacturer - Parke Davis India Ltd
1216/4A PAVILLE HOUSEOFF VEER SAVARKAR MARG PRABHADEVI MUMBAI MH 400025 IN

Expires on or after
October, 2025

liver
Limited information is available regarding the use of Adroyd 5mg Tablet in individuals with liver disease. It is strongly advised to seek guidance from a healthcare professional concerning the safety and appropriateness of using this medication in such cases.

kidney
Limited information is known about using Adroyd 5mg Tablet in patients with kidney disease. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Adroyd 5mg Tablet.

driving
Adroyd 5mg Tablet generally does not impact your driving ability.

pregnancy
Adroyd 5mg Tablet may not be safe to use during pregnancy. Animal studies have shown harmful effects on the developing baby. Your doctor will consider the benefits and risks before prescribing it to you. Please consult your doctor.

breastfeeding
Adroyd 5mg Tablet is likely safe during breastfeeding, with limited data showing no significant risk to the baby. To minimize exposure, remove excess solution with a tissue.
Habit Forming | No |
Chemical Class | Imidazole Derivative |
Therapeutic Class | - |
Action Class | Sympthatomimmetics- alpha 1 (Nasal) |
₹25.65
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025